ONCOLOGÍA AL DÍA

Dr Rafael Rosell presents a Translational Lung Cancer Research special issue

11/04/2013


Dr Rafael Rosell, as author and Associate Editor-in-Chief of this new journal, presents one of two monographic issues detailing the state-of-the-art in lung cancer research, laboratory techniques and novel therapeutic targets.
 
This special issue features an original contribution on Circulating Tumor Cells (CTCs) from medical oncologists at the Dr Rosell Oncology Institute and Pangaea Biotech S.L laboratory investigators, as well as review articles on topics such as targeting ALK, ROS1, EML4-ALK and FGFR1 by prestigious international investigators from leading institutions such as the Sarriá Chemistry Institute (Institut Químic de Sarrià), Barcelona and the Center for Integrated Oncology Cologne-Bonn, Germany. Many of these contributions reflect the fruits of ongoing collaborations between the Dr Rosell Oncology Institute and these institutions.
 
Video preface to the Special Issue
Vol 2, No 2 (April 2013): Translational Lung Cancer Research
 

volver